Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-23

Clinical Trial Update: Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Mesenchymal Stem Cells for healing diabetic foot ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Cell to Cure ApS | Conditions: Diabetic Foot Ulcer, Mesenchymal Stromal Cells | Phase 1 | Status: TERMINATED